1/28/2022 | 3004900008 | MEDICINES FOR CLINICAL STUDIES CONSISTING OF MIXED PRODUCTS FOR USE IN THERAPEUTIC / PREVENTIVE PURPOSES, PACKED IN THE FORM OF DOSE. DOSAGE FORMS, NOT FOR VETERINARY, DO NOT CONTAIN ETHYL ALCOHOL, DO NOT | 6.7 | 81312.5 | Germany | Unknown | BAYER JSC |
1/10/2022 | 3004900008 | DRUGS, CONSISTING OF MIXED/UNMIXED PRODUCTS, FOR EXAMINATION OF UNREGISTERED MEDICINAL PRODUCTS (REGISTRATION OF MEDICINAL PRODUCTS), NOT ethyl alcohol, NOT FOR THERAPEUTIC USE, NOT FOR VETERINARY, NOT FOR SALE: | 0.15 | 1931.49 | Spain | MOSCOW RUSSIA | REPRESENTATIVE OFFICE OF JSC ELI LILLY VOSTOK SA |
1/13/2022 | 3004900008 | MEDICINES CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR USE FOR THERAPEUTIC OR PREVENTIVE PURPOSES, PACKED IN THE FORMS OF DOSED DOSAGE FORMS NOT SOD.YOD. | 14.4 | 107847.5 | Puerto Rico | MOSCOW RUSSIA | PPD DEVELOPMENT SMOLENSK FROM GLOBAL CLINICAL SUPPLIES23A KIROVOGRADSKAYA STR 117534 MOSCOW LLC |
1/15/2022 | 3004900008 | MEDICINES CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR USE FOR THERAPEUTIC OR PREVENTIVE PURPOSES, PACKED IN THE FORM OF DOSAGES NOT SOD.IOD, WITHOUT SOD.ALCOHOL, FOR RESEARCH ON | 2.99 | 50640 | United States of America | MOSCOW RUSSIA | PPD DEVELOPMENT SMOLENSK FROM GLOBAL CLINICAL SUPPLIES23A KIROVOGRADSKAYA STR 117534 MOSCOW LLC |
1/30/2022 | 3004900008 | MEDICINES FOR CLINICAL STUDIES ACCORDING TO PROTOCOL No. CBYL719C2202, COMP. FROM MIXED PRODUCTS, FOR USE. FOR THERAPEUTIC / PREVENTIVE PURPOSES, PACKED IN THE FORM OF DOSE. MEDICINE. FORMS, NOT FOR VETERINARY, NOT SOD. ETHYL | 7.7 | 169760.2 | Switzerland | Unknown | NOVARTIS PHARMA LLC |
1/28/2022 | 3004900008 | MEDICINES, FOR CLINICAL STUDIES ACCORDING TO PROTOCOL No. CINC280A2201, CONSISTING OF MIXED PRODUCTS, FOR USE. FOR THERAPEUTIC / PREVENTIVE PURPOSES, PACKED IN THE FORM OF DOSAGE. MEDICINE. FORMS, NOT FOR SALE, NOT FOR | 5.52 | 536.73 | Germany | Unknown | NOVARTIS PHARMA LLC |
1/31/2022 | 3004900008 | MEDICINES CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC USE, PACKED IN THE FORMS OF DOSAGE; FOR CLINICAL STUDIES ACCORDING TO THE BRIGATINIB 3001 PROTOCOL | 13.61 | 138631.3 | United States of America | Unknown | IMP LOGISTICS JSC |
1/30/2022 | 3004900008 | MEDICINES FOR CLINICAL STUDIES ACCORDING TO PROTOCOL No. CLDK378A2X01B, CONSISTING OF MIXED PRODUCTS FOR USE IN THERAPEUTIC / PREVENTIVE PURPOSES, PACKED IN THE FORM OF DOSE. MEDICINE. FORM; NOT FOR SALE, NOT FOR | 5.4 | 49537.4 | Switzerland | Unknown | NOVARTIS PHARMA LLC |
1/24/2022 | 3004900008 | MEDICINES FOR CLINICAL STUDIES ACCORDING TO PROTOCOL No. CABL001A2301, CONSISTING OF MIXED PRODUCTS, FOR USE. FOR THERAPEUTIC OR PREVENTIVE PURPOSES, PACKED IN THE FORMS OF DOSAGE; NOT FOR SALE, NOT FOR | 0.54 | 480.16 | Switzerland | Unknown | NOVARTIS PHARMA LLC |
1/24/2022 | 3004900008 | MEDICINES FOR CLINICAL INVESTIGATIONS, CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PREVENTIVE USE, PACKED IN THE FORMS OF DOSAGE; NOT FOR VETERINARY, NOT | 9.9 | 25705.4 | Germany | Unknown | REPRESENTATIVE OFFICE OF AKYUVIA RDS GEZMBH |